www.elsevier.com / locate / livprodsci
Effects of recombinant ovine placental lactogen and
recombinant ovine growth hormone on growth of lambs and
q
milk production of ewes
a a b c ,
*
Haim Leibovich , Arieh Gertler , Fuller Bazer , Elisha Gootwine
a
Institute of Biochemistry, Food Science and Nutrition, Faculty of Agriculture, The Hebrew University of Jerusalem, Rehovot, Israel b
Center for Animal Biotechnology and Genomics, Institute of Biosciences and Technology, Texas A&M University System Health Science Center, College Station, TX 77843-2471, USA c
Institute of Animal Science, ARO, The Volcani Center, P.O. Box 6, 50250 Bet Dagan, Israel
Received 12 August 1999; received in revised form 20 December 1999; accepted 20 May 2000
Abstract
The somatogenic and galactopoietic effects of recombinant ovine placental lactogen (oPL) were compared with the effects of recombinant ovine growth hormone (oGH) in post-weaned growing lambs and in lactating ewes. In two experiments that each lasted 35 days, 2-month-old lambs were given daily subcutaneous injections (0.1 mg / kg live weight) of oPL or oGH, and their daily growth rates were compared with those of non-treated control lambs. Ovine GH and oPL had similar
profound (P,0.01) growth-stimulating effects, enhancing lamb growth by 10 to 25%. In two other experiments, lactating
ewes were injected with oGH or oPL (0.1 mg / kg live weight / day) for 14 days in mid-lactation. Treatment with oGH
increased (P,0.001) daily milk production by up to 55% over control ewes. Ovine PL increased (P,0.01) milk production
by up to 25%. In all experiments, treatment of lambs or lactating ewes with oGH, but not with oPL increased (P,0.05)
serum insulin-like growth factor-I concentrations. It is concluded that oPL and oGH have similar somatogenic effects in
lambs. Both hormones exhibited galactopoietic effects, but oGH was considerably more potent than oPL. 2001 Elsevier
Science B.V. All rights reserved.
Keywords: Placental lactogen; Growth hormone; Growth; Milk production; Sheep; IGF-I
1. Introduction ruminants synthesize and secrete unique proteins that
belong to the growth hormone / prolactin (GH / PRL) Similar to other mammalian species, placentae of family and are called placental lactogens (PLs) (Byatt et al., 1992b). Ovine (o) (Martal and Djiane, 1975; Warren et al., 1990) and bovine (b) (Murthy et
q
Contribution from the Agricultural Research Organization, al., 1982) PLs are 22 to 23 kDa proteins which are, The Volcani Center, Bet Dagan, Israel. No. 337 / 99, 1999 series.
based on structural analysis and gene mapping, more *Corresponding author. Tel.: 1972-3-9683-752; fax:1
972-8-closely related to their respective PRL than GH 475-075.
E-mail address: [email protected] (E. Gootwine). (Byatt et al., 1992b; Gootwine and Yossefi, 1998).
One unique property of ruminant PL which was 2. Materials and methods
observed early on is their ability to bind to both PRL
and GH receptors, including receptors for human The Volcani Center Animal Care Committee ap-(h)GH (Forsyth, 1986; Anthony et al., 1995a,b). This proved the experimental protocols used in this observation suggested that GH and PL may have research.
similar biological activities. However, attempts to
prove this hypothesis using in vitro experimental 2.1. Materials systems yielded contradictory results depending on
whether a homologous or a heterologous model Recombinant oPL and oGH were prepared as system was chosen. Both bPL and oPL were potent described previously (Sakal et al., 1997). Human agonists in FDC-11P cells stably transfected with insulin-like growth factor-I (IGF-I) and antiserum human or rabbit GH receptors, and their activities against IGF-I were obtained from Fugisawa Pharma-were comparable with those of hGH and oGH, ceutical (Osaka, Japan). Antiserum against oGH was respectively (Helman et al., 1997, 1998; Sakal et al., obtained from the National Hormone Pituitary Pro-1997). In contrast, in ‘‘293’’ cells transiently trans- gram (University of Maryland School of Medicine, fected with oGH or hGH receptors, ruminant PL MD, USA). Goat anti-rabbit IgG and normal rabbit were active only in cells transfected with hGH serum were purchased from Bio-Makor (Rehovot, receptors (Herman et al., 1999). In cells transfected Israel). Antiserum against oPL was prepared in
125 with oGH receptors, only oGH acted as an agonist, rabbits in our laboratory. Carrier-free Na[ I] was whereas ruminant PL, despite their ability to bind to purchased from New England Nuclear Corp. (Bos-those receptors, exhibited antagonistic activity. ton, MA, USA).
Therefore, it was concluded that ruminant PL can
bind to, but not homodimerize, oGH receptors 2.2. Animals, housing and feeding (Herman et al., 1999).
Results from in vivo comparisons of PL and GH The experiments were conducted with the Kat-bioactivities are also inconsistent. Whereas adminis- zenelbugen dairy flock, which includes 600 Assaf tration of both bPL or bGH increased growth and breeding ewes, at Moshav Talmai Elazer. This flock milk production in rats, only bGH affected milk is kept indoors all year round and the ewes are fed yield in dairy cows (Byatt et al., 1992a). Further- according to Israeli Ministry of Agriculture recom-more, oPL failed to show GH-like galactopoietic mendations (Landau and Leibovich, 1992). All the properties when injected into ewes (Min et al., lambs of this flock are routinely separated from their 1995). Bovine GH, but not bPL, had stimulatory dams on the day of lambing, and are moved to an effects on lamb growth rate in one study (McLaug- artificial rearing unit where they receive a commer-hlin et al., 1993) while, in another study, administra- cial milk replacer ad libitum until weaning at approx-tion of oPL to growing lambs significantly increased imately 25 days of age. Following weaning, lambs their growth rate, whereas bGH did not (Min et al., have free access to concentrates, hay and water. 1996). This latter result contradicts several other Ewes are milked at 08:00 and 16:00 daily from the studies where bGH had a growth-promoting effect in day of lambing until milk yield decreases to approxi-lambs (Wagner and Veenhuizen, 1978; Rosemberg et mately 0.5 l / day.
al., 1989).
Recombinant oPL (Colosi et al., 1989; Sakal et al., 2.3. Growth-promoting effects following 1997) and bPL (Krivi et al., 1989) have been administration of oPL and oGH
prepared, and were produced in our laboratory
protein) ad libitum and hay at 0.1 kg / head / day. infrared analyzer (Milkoscan 134; N. Foss Electric, Lambs were treated daily at 10:00 for 35 days with Hillerod, Denmark).
saline solution containing 0.1 mg / kg body weight of
oPL (oPL group) or oGH (oGH group), or received 2.6. Radioimmunoassays saline only (control group). Lambs were weighed at
the beginning of the injection period and once a Serum concentrations of oGH (Peri et al., 1993), week thereafter until the end of the injection period. IGF-I (Breier et al., 1991) and oPL (Kann, 1971) Group feed consumption was monitored daily. Blood were determined as described previously. Iodination samples for hormone assays were collected from the of oGH and oPL was performed as described previ-jugular vein on the morning time of day 34 of the ously (Gertler et al., 1984). The inter- and intra-injections, prior to the daily hormone administration, assay coefficients of variation were 12.4% and 8.7% to obtain serum, which was stored at 2208C until for IGF-I, 10.4% and 6.2% for oGH, and 8.8% and assayed. 6.4% for oPL, respectively.
2.7. Data analyses 2.4. Galactopoietic effects following administration
of oPL and oGH
Lamb growth rates were calculated by fitting linear regressions to the body weight measurements Forty-five multiparous ewes that lambed during 2
and then subjecting them to analysis of variance. The weeks in October 1997 and 143 multiparous ewes
model included the main fixed effects of experiment that lambed during 2 weeks in October 1998 were
(1, 2) and experimental group (oPL, oGH and used in two experiments to determine daily milk
control). Lamb weight at the beginning of the production, recorded weekly from lambing. In each
experiment was used as a covariate. Results from experiment, at about 8 weeks after lambing and
each of the milk production experiments were ana-when all ewes had passed their peak of lactation,
lyzed separately. Data on milk production on each they were assigned to three groups. Distribution of
day of recording was analyzed by analysis of vari-ewes into the different groups was according to their
ance. The model included experimental group as the weight and their daily milk production averaged
main effect, and milk production on day 0, days from across the last three daily milk records. The ewes
lambing and ewe body weight at the beginning of the were treated daily at 17:00 for 14 days with saline
injection period were taken as covariates. Serum solution containing 0.1 mg / kg body weight of either
hormone concentrations and milk composition were oPL (oPL group) or oGH (oGH group), or received
subjected to analysis of variance to test for effects of saline only (control group). Milk production was
treatment within day of sampling. Statistical analyses monitored the day before the injections were begun
were conducted using the Statistical Analysis Insti-(day 0) and then every 3 to 5 days, for up to 28 days.
tute (SAS) computer package (1985). All data are Body weight was recorded for all ewes before and at
expressed as least squares means and standard errors. the end of the hormonal injection periods. Group
Differences of P,0.05 were considered significant. feed consumption was monitored daily in the first
experiment only. Blood samples were collected 10 to 11 days after initiation of hormone treatments at
3. Results
10:00 to obtain serum for assay for concentrations of IGF-I, oGH and oPL.
3.1. Comparison of oGH and oPL effects in growing lambs
2.5. Milk composition analysis
Table 1
Growth performance, and oGH, oPL and IGF-I serum concentrations (LS mean6S.E.M.) of control lambs and lambs treated daily for 35 1
Initial average body weight (kg) 25.060.9 24.460.9 24.660.9
a b b
Within rows, means with different superscripts are different (P,0.05). 2
Measured 34 days after the beginning of the injection periods. N.D., Not detectable.
profound and similar growth-stimulating effects of 3.2. Comparison of oGH and oPL effects in approximately 10 and 25%, in experiments 1 (P, lactating ewes
0.01) and 2 (P,0.005), respectively. The relative
Table 2
Milk yield and composition (LS mean6S.E.M.) on the 13th day of the injection period of ewes belonging to the control, oPL and
1 oGH groups
Experimental group
Control oPL oGH
No. of ewes 15 15 15
a a b
Milk yield (l) 1.9160.1 2.1460.1 2.9760.1 Total solids (%) 17.160.3 17.060.2 16.460.2
a b b
Lactose (%) 5.160.5 4.760.4 4.760.4
a a b
Protein (%) 5.660.1 5.660.1 5.160.1 Fat (%) 5.660.2 5.760.2 5.560.2
1 a,b
Within rows, means with different superscripts are different (P,0.05).
not detectable in control ewes or ewes treated with oGH, but averaged 73611 ng / ml in ewes treated with oPL. Feed intake for the oGH and oPL-treated ewes averaged 3.6 and 3.8 kg DM / d, respectively, numerically higher than the feed intake in control ewes (3.1 kg DM / d).
Fig. 1. Milk production in ewes treated daily for 14 days with 0.1
Results on milk composition are summarized in mg / kg body weight of oPL (triangles), oGH (open circles) or
saline (squares). The values are given as LS means6S.E.M. The Table 2. The increase (P,0.05) in milk yield in the numbers of ewes in each treatment were 15 in experiment 1 and oPL and the oGH groups did not affect total solids or 47–48 in experiment 2.
fat concentration. However, percent protein was lower (P,0.05) in the oGH group and percent injection (P,0.01), being 25 and 20% in experi- lactose was lower (P,0.05) in both the oPL and ments 1 and 2, respectively. Upon cessation of the oGH groups.
hormonal treatments, there was a decrease in milk production within 10 to 14 days and daily milk
yields for ewes in the treatment groups were not 4. Discussion
different from those of the control ewes. IGF-I
concentrations in control ewes on days 10 to 11 of In this study, we have compared for the first time the injection periods were 88611 and 126610 ng / the in vivo somatogenic and lactogenic activities of ml in experiments 1 and 2, respectively. While oPL oGH and oPL in a homologous system. Our results administration did not significantly change serum indicate that the growth-promoting activity of oPL in concentrations of IGF-I (101611 and 12169 ng / ml lambs is similar to that of oGH. However, the in experiments 1 and 2, respectively), concentrations galactopoietic effects of oPL in ewes were sig-of IGF-I in oGH-treated groups increased (P,0.05) nificantly less than for oGH. The mechanism(s) to 265611 and 294614 ng / ml in experiments 1 and responsible for the stimulatory effects of oPL on 2, respectively. growth and milk production may differ from those of Ovine GH and oPL serum concentrations were oGH, as only oGH treatment resulted in an increase determined in ewes only in experiment 1, 10 to 11 in serum IGF-I concentrations.
bGH, but not bPL, stimulated growth of lambs genetic selection for high milk production as dairy (McLaughlin et al., 1993). The growth-promoting cows. Thus, the high response to the oGH in ewes effects of oPL in our study (10–25%), obtained by may reflect the difference between the actual levels treating 2-month-old lambs for 35 days, are similar of production and the physiological potential for to the 12% increase in growth rate of 3-day-old production. Interestingly, injection of bGH into lambs following treatment with oPL for 21 days lactating goats has also increased milk production by (Min et al., 1996). In contrast, Ogawa et al. (1995) 50–60% (Jammes et al., 1996).
saw no somatogenic and anticatabolic effects of oPL It should be emphasized that the in vivo following daily injection of 2-month-old lambs for 5 somatogenic and lactogenic effects of oPL in the days. Thus, collectively, these results indicate that present study occurred during physiological states of the somatogenic effect of PL (as compared with that growth and lactation when oPL is not naturally of GH) may depend on the age of the lambs, the present. Thus, our results advance our understanding duration of the injection period and the homology of of the biological potency of oPL, but its physiologi-the experimental system. cal role during pregnancy needs to be investigated
In two experiments conducted with lactating ewes further.
growth hormone, and placental lactogen. J. Dairy Sci. 69, new ideas on the oPL specific mechanism of action,
886–903. which could explain the similar but different oGH
Gertler, A., Ashkenazi, A., Madar, Z., 1984. Binding sites of and oPL activity in the present study. human growth hormone and ovine and bovine prolactins in the mammary gland and the liver of lactating dairy cow. Mol. Cell. Endocrinol. 34, 51–57.
Gertler, A., Hauser, S.D., Sakal, E., Vashdi, D., Staten, N.R.,
Acknowledgements
Freeman, J.J., Krivi, G.G., 1992. Preparation, purification and determination of the biological activities of 12 N terminus-We acknowledge the technical help of Mr. Eyal
truncated recombinant analogues of bovine placental lactogen. Vardi in the preparation of recombinant oPL and J. Biol. Chem. 267, 12655–12659.
oGH, Ms. Nava Chapnik-Cohen for her help in the Gootwine, E., Yossefi, S., 1998. Genetic mapping of the ovine Nb2 bioassays and Mr. Moti Katzenelbugen for his placental lactogen gene to sheep chromosome 20. Anim. Genet.
27, 69. cooperation. We also thank the National Institute of
Helman, D., Staten, N.R., Byatt, J., Grosclaude, J., McKinnie, Health, Hormone Program for a gift of anti IGF-I
R.E., Djiane, J., Gertler, A., 1997. Site-directed mutagenesis of antibodies. This research was supported by Research
recombinant bovine placental lactogen at lysine-73 leads to Grant No. US-2643-95 from BARD, The United selective attenuation of its somatogenic activity. Endocrinology States–Israel Binational Agricultural Research and 138, 4069–4080.
Development Fund. Helman, D., Staten, N.R., Grosclaude, J., Daniel, N., Nespoulous, C., Djiane, J., Gertler, A., 1998. Novel recombinant analogues of bovine placental lactogen. G133K and G133R provide a tool to understand the difference between the action of prolactin and
References growth hormone receptors. J. Biol. Chem. 273, 16067–16074.
Herman, A., Helman, D., Livnah, O., Gertler, A., 1999. Ruminant Anthony, R.V., Liang, R., Kayl, E.P., Pratt, S.L., 1995a. The placental lactogens act as antagonists to homologous growth growth hormone / prolactin gene family in ruminant placentae. hormone receptors and as agonists to human or rabbit growth J. Reprod. Fertil. (Suppl.) 49, 83–95. hormone receptors. J. Biol. Chem. 274, 7631–7639. Anthony, R.V., Pratt, S.L., Liang, R., Holland, M.D., 1995b. Herman, A., Bignon, C., Daniel, N., Grosclaude, N., Gertler, A.,
Placental–fetal hormonal interactions: impact on fetal growth. Djiane, J., 2000. Functional heterodimerization of prolactin and J. Anim. Sci. 73, 1861–1871. growth hormone receptors by ovine placental lactogen. J. Biol. Bauman, D.E., Vernon, R.G., 1993. Effects of exogenous bovine Chem. 275, 6295–6301.
somatotropin on lactation. Annu. Rev. Nutr. 13, 437–461. Jammes, H., Disenhaus, C., Ouriet, V., Kayser, C., Postel-Vinay, Breier, B.H., Gallaher, B.W., Gluckman, P.D., 1991. Radioim- M.C., Djiane, J., 1996. Growth hormone-binding protein in the munoassay for insulin-like growth factor-I: solution to some goat: characterization, evolution under receptor levels. Domest. potential problems and pitfalls. J. Endocrinol. 128, 347–357. Anim. Endocrinol. 13, 477–489.
Byatt, J.C., Epparo, P.J., Munyakazi, L., Sorbet, R.H., Veenhuizen, Kann, G., 1971. Changes of plasma concentrations of luteinizing J.J., Curran, D.F., Collier, R.J., 1992a. Stimulation of milk hormone and prolactin during the estrous cycle of ewes. C. R. yield and feed intake by bovine placental lactogen in the dairy Acad. Sci. Hebd. Seances Acad. Sci. D 272, 2934–2937. cow. J. Dairy Sci. 75, 1216–1223. Kann, G., Delobelle-Deroide, A., Bbelair, L., Gertler, A., Djiane, Byatt, J.C., Warren, W.C., Eppard, P.J., Staten, N.R., Krivi, G.G., J., 1999. Demonstration of in vivo mammogenic and lactogenic Collier, R.J., 1992b. Ruminant placental lactogens: structure effects of recombinant placental lactogen and mammogenic and biology. J. Anim. Sci. 70, 2911–2923. effect of recombinant ovine GH in ewes during artificial Chiofalo, V., Baldi, A., Savoini, G., Polidori, F., Dell’Orto, V., induction of lactation. J. Endocrinol. 160, 365–377.
Politis, I., 1999. Response of dairy ewes in late lactation to Krivi, G.G., Hauser, S.D., Stafford, J.M., Collier, J.M., Byatt, J.C., recombinant bovine somatotropin. Small Rum. Res. 3, 119– 1989. Structure and biological activity of recombinant bovine
125. placental lactogen. In: The Endocrine Society 71st Annual
Colosi, P., Thordarson, G., Hellmiss, R., Singh, K., Forsyth, I.A., Meeting Abstracts, Abstract No. 1523.
Gluckman, P.D., Wood, W.I., 1989. Cloning and expression of Landau, S., Leibovich, H., 1992. In: [Nutritional Requirements of ovine placental lactogen. Mol. Endocrinol. 3, 1462–1469. Sheep]. Israel Ministry of Agriculture, Extension Services, Tel Fernandez, N., Rodrigues, M., Peris, C., Barcelo, M., Moolina, Aviv, pp. 1–8, (in Hebrew).
M.P., Torres, A., 1995. Bovine somatotropin dose titration in Martal, J., Djiane, J., 1975. Purification of a lactogenic hormone in lactating dairy ewes. 1. Milk yield and milk composition. J. sheep placenta. Biochem. Biophys. Res. Commun. 65, 770–
Dairy Sci. 78, 1078–1082. 778.
R.J., Baile, C.A., 1993. Performance, clinical chemistry, and Ogawa, E., Breier, B.H., Bauer, M.K., Gluckman, P.D., 1995. carcass responses of finishing lambs to recombinant bovine Ovine placental lactogen lacks direct somatogenic and an-somatotropin and bovine placental lactogen. J. Anim. Sci. 71, ticatabolic actions in the postnatal lamb. J. Endocrinol. 145,
3307–3318. 87–95.
Min, S.H., Mackenzie, D.D.S., McCutcheon, S.N., Breier, B.H., Rosemberg, E., Thonney, M.L., Butler, W.R., 1989. The effect of Gluckman, P.D., 1995. Comparative effects of recombinant bovine growth hormone and thyroxine on growth rate and ovine placental lactogen and bovine growth hormone on carcass measurements in lambs. J. Anim. Sci. 67, 3300–3312. galactopoiesis in ewes. J. Dairy Sci. 80, 640–645. Sakal, E., Bignon, C., Kantor, A., Leibovitch, H., Shamay, A., Min, S.H., Mackenzie, D.D.S., Breier, B.H., McCutchen, S.N., Djiane, J., Gertler, A., 1997. Large-scale preparation and Gluckman, P.D., 1996. Growth-promoting effects of ovine characterization of recombinant ovine placental lactogen. J. placental lactogen (oPL) in young lambs: comparison with Endocrinol. 152, 317–327.
bovine growth hormone provides evidence for a distinct effect Statistical Analysis System Institute, 1985. SAS User’s Guide. of oPL on food intake. Growth Regul. 6, 144–151. SAS Institute, Cary, NC.
Murthy, G.S., Schellenberg, C., Friesen, H.G., 1982. Purification Wagner, J.F., Veenhuizen, E.L., 1978. Growth performance, and characterization of bovine placental lactogen. Endocrinolo- carcass deposition and plasma hormone levels in wether lambs gy 111, 2117–2124. when treated with growth hormone and thyroprotein. J. Anim. Peri, I., Gertler, A., Bruckental, I., Barash, H., 1993. The effect of Sci. 47 (Suppl. 1), 397, (Abstr.).
